Glucagon‐like peptide‐1 receptor agonist, liraglutide, reduces heroin self‐administration and drug‐induced reinstatement of heroin‐seeking behaviour in rats

Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats

(2020) Joaquin E. Douton et al.   BEHAVIOURAL PHARMACOLOGY

Effects of a glucagon-like peptide-1 analog on appetitive and consummatory behavior for rewarding and aversive gustatory stimuli in rats

(2020) Joaquin E. Douton et al.   PHYSIOLOGY & BEHAVIOR

Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018

(2019) Gery P. Guy et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats

(2019) Yafang Zhang et al.   NEUROPSYCHOPHARMACOLOGY

Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats

(2018) Nicole S. Hernandez et al.   NEUROPSYCHOPHARMACOLOGY

The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice

(2017) Morgane Thomsen et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents

(2015) Daniel Vallöf et al.   ADDICTION BIOLOGY

Treatment of Obesity in 2015

(2015) Alpana P. Shukla et al.   Journal of Cardiopulmonary Rehabilitation and Prevention

The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice

(2015) Gunnar Sørensen et al.   PHYSIOLOGY & BEHAVIOR

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

(2014) Anna Secher et al.   JOURNAL OF CLINICAL INVESTIGATION

Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness

(2013) Evgeny Krupitsky et al.   ADDICTION

Escalation of drug self-administration as a hallmark of persistent addiction liability

(2013) Scott Edwards et al.   BEHAVIOURAL PHARMACOLOGY

The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice

(2013) Emil Egecioglu et al.   PLoS One

The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors

(2012) S. L. Dickson et al.   JOURNAL OF NEUROSCIENCE

GLP-1 analog attenuates cocaine reward

(2012) D L Graham et al.   MOLECULAR PSYCHIATRY

Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4

(2011) Scott E. Kanoski et al.   ENDOCRINOLOGY

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

(2011) Scott E. Kanoski et al.   NEUROPHARMACOLOGY

Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats

(2011) Matthew R. Hayes et al.   Obesity

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

(2010) Richard M Bergenstal et al.   LANCET

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

(2009) John B Buse et al.   LANCET

Incretin-based therapies for type 2 diabetes mellitus

(2009) Julie A. Lovshin et al.   Nature Reviews Endocrinology

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

(2008) Daniel J Drucker et al.   LANCET

Heroin self-administration: I. Incubation of goal-directed behavior in rats

(2008) Kara L. Kuntz et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR